5-Methyl-2-(4-nitro-phenyl)-thiazole-4-carboxylic acid, 95.0%, 1g

(R,E)-4-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-1-cyclopropylpent-2-en-1-one, 98%, 10g

2,4-Dibromobenzoyl chloride, 95.0%, 25g

6-G1F 2AB (500pmol/vial)>95.0%(HPLC)1vial

5,11-Dihydro-2-[[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]amino]-11-methyl-5-(2,2,2-trifluoroethyl)-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one, 98%, 100mg

6-Bromo-2-chloroquinazolin-4-amine, 95.0%, 5g

1-Chloro-3,5-dimethoxybenzene, 98.0%, 5g

1-(5-Fluoro-pyrimidin-2-yl)-pyrrolidin-3-ol, 500mg

3,5-Dichlorobenzhydrol, 97.0%, 250mg

4'-Demethylepipodophyllotoxin, 98%, 5g

6-Fluoroquinoline>98.0%(GC)5g

3-Fluoro-2-pyridinecarboxaldehyde, 95.0%, 5g

Methyl 2-amino-3-hydroxybutanoate hydrochloride, 95.0%, 10g